| Market Cap | ₹787Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 34.13 |
| EPS(TTM) | 27.91 |
| P/B Ratio | 4.73 |
| Dividend Yield | 0.21% |
| Industry P/E | 33.47 |
| Book Value | 201.38 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Titan Biotech Limited |
| Managing Director | Mr. Naresh Singla |
| BSE Symbol | 524717 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 71.29 | ||
| Anthem Biosciences | NA (0.00%) | 74.67 | ||
| Onesource Specialty Pharma | NA (0.00%) | 502.94 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.58 |